3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Renal Insufficiency, Chronic
1
Renal Insufficiency
1
Lymphoma, Follicular
1
Heart Failure
1
Interventions
Dexamethasone
10
Bortezomib
7
Lenalidomide
4
isatuximab
3
Calcium Dobesilate
3
pomalidomide
2
Thalidomide
2
Gemcitabine
2
Cyclophosphamide
2
vinflunine
1
melflufen
1
glucarpidase
1
gallium 68 PSMA-11
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
carfilzomib
1
auricularum
1
Tablets
1
Ranitidine
1
Pluvicto
1
L-melphalanyl-p-L-fluorophenylalanine ethyl ester
1
Eplerenone
1
Doxorubicin
1
Diphenhydramine
1
Carboplatin
1
Bendamustine Hydrochloride
1
BHQ880
1
Acetaminophen
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Renal Insufficiency
×
Eplerenone
×
Clear all
NCT07029503
2026-02-24
SCARF-1
Karolinska Institutet
Phase 2
Recruiting
40 enrolled